Abivax Stock (NASDAQ: ABVX) stock price, news, charts, stock research, profile.
Open | $13.860 |
Close | $14.310 |
Volume / Avg. | 420.218K / 66.661K |
Day Range | 13.800 - 14.400 |
52 Wk Range | 7.995 - 17.020 |
Market Cap | $873.297M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | - |
Days to Cover | 1.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Abivax (NASDAQ: ABVX) through any online brokerage.
Other companies in Abivax’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Abivax (NASDAQ: ABVX) was reported by BTIG on Monday, May 20, 2024. The analyst firm set a price target for 43.00 expecting ABVX to rise to within 12 months (a possible 209.80% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Abivax (NASDAQ: ABVX) is $13.88 last updated May 21, 2024 at 9:15 AM EDT.
There are no upcoming dividends for Abivax.
Abivax’s FY earnings are confirmed for Tuesday, April 2, 2024.
There is no upcoming split for Abivax.
Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.